NEW YORK, June 16, 2021 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by
Kindred Biosciences, Inc. (NASDAQ: KIN) and its board of directors
concerning the proposed acquisition of the company by Elanco Animal
Health Incorporated (NYSE: ELAN). Stockholders will receive
$9.25 for each share of Kindred
Biosciences stock that they hold. The transaction is valued at
approximately $440 million and is
expected to close in the third quarter of 2021.
If you are a stockholder of Kindred Biosciences, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/kin/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-kindred-biosciences-inc-301314233.html
SOURCE Rowley Law PLLC